Biden-era bill targets ban on federal Medicaid funding for gender transition care for minors
Stalled
No legislative action in over 90 days.
215–201
Transgender minors enrolled in Medicaid would be the most directly affected group. The bill would cut off federal funding for puberty blockers, hormones, and surgeries that are part of gender transition care. For families who rely on Medicaid and have transgender children, this could mean paying out of pocket for care or going without it entirely. The bill also sends a broader signal about how the federal government views gender-affirming care for young people.
Motion to reconsider laid on the table Agreed to without objection.
On passage Passed by the Yeas and Nays: 215 - 201 (Roll no. 362).
Passed/agreed to in House: On passage Passed by the Yeas and Nays: 215 - 201 (Roll no. 362).
The House of Representatives voted to approve this bill. It now goes to the Senate.
On motion to recommit Failed by the Yeas and Nays: 204 - 212 (Roll no. 361).
Considered as unfinished business.
On Motion to Recommit
Covers House passage of H.R. 498 (Do No Harm in Medicaid Act) and the 215–201 vote to block federal Medicaid funding for gender-transition procedures for minors.
Duplicate-format coverage (AMP) of the House vote and bill provisions restricting federal Medicaid funding for minors’ gender-transition care.
Reacting to House passage of H.R. 498, the caucus criticizes the measure as restricting medically necessary care for trans youth on Medicaid.
Document Type
Congressional Bill
Official Title
Do No Harm in Medicaid Act
Analysis generated by AI. Always verify with official sources.